The present invention relates to the use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species.
本发明涉及使用
黄嘌呤衍
生物治疗增加的颅内压力、继发性缺血以及与细胞毒性反应氧化物
水平升高相关的疾病。